PYPDPolyPid Ltd.

PYPD Stock Price, Valuation & Chart | PolyPid Ltd.

Compare

$5.300-0.03 (-0.56%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Biotechnology PYPD intrinsic value PYPD calculated fair value vs price

Overview Financials Dividends Ratios

PYPD Historical price chart

PYPD Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization101.14M

PE Ratio-3.58

EPS-1.48

Trading Volume143.78K

Today's High/Low5.34/5.16

Dividend Yield0.00

52 Week High/Low5.73/3.06

Shares Outstanding19.08M

PYPD Financial Statement

PYPD Analyst ratings

PYPD Analysis & performance metrics

PYPD Company profile

PolyPid Ltd., a late-stage biopharma company, develops, manufactures, and commercializes products based on polymer-lipid encapsulation matrix (PLEX) platform to address unmet…

PolyPid Ltd., a late-stage biopharma company, develops, manufactures, and commercializes products based on polymer-lipid encapsulation matrix (PLEX) platform to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in Phase III clinical trial for the prevention of sternal (bone) surgical site infections (SSIs), as well as for the prevention of abdominal (soft…

PYPD Management team

Name

Position

Dikla Czaczkes AkselbradCEO

Chief Executive Officer & Director

Rivi Lev-ari

Vice President of Human Resource

Maria Rubin

Executive Vice President of Operations

Tal Vilnai

General Counsel & Corporate Secretary

Jonny MissulawinCFO

Chief Financial Officer

Dalit HazanCEO

Deputy Chief Executive Officer and Executive Vice President of R&D, Clinical & Regulatory Affairs

Jean-Marc Hagai Pharm.D.

Chief Commercial Officer

Nurit Tweezer-Zaks M.B.A., M.D.

Chief Medical Officer

Name

Position

Dikla Czaczkes AkselbradCEO

Chief Executive Officer & Director

Rivi Lev-ari

Vice President of Human Resource

Maria Rubin

Executive Vice President of Operations

Tal Vilnai

General Counsel & Corporate Secretary

Jonny MissulawinCFO

Chief Financial Officer

Dalit HazanCEO

Deputy Chief Executive Officer and Executive Vice President of R&D, Clinical & Regulatory Affairs

Jean-Marc Hagai Pharm.D.

Chief Commercial Officer

Nurit Tweezer-Zaks M.B.A., M.D.

Chief Medical Officer

Management Team

Dikla Czaczkes AkselbradCEO

Chief Executive Officer & Director

Rivi Lev-ari

Vice President of Human Resource

Maria Rubin

Executive Vice President of Operations

Tal Vilnai

General Counsel & Corporate Secretary

Jonny MissulawinCFO

Chief Financial Officer

Dalit HazanCEO

Deputy Chief Executive Officer and Executive Vice President of R&D, Clinical & Regulatory Affairs

Jean-Marc Hagai Pharm.D.

Chief Commercial Officer

Nurit Tweezer-Zaks M.B.A., M.D.

Chief Medical Officer

Management

Dikla Czaczkes AkselbradCEO

Chief Executive Officer & Director

Rivi Lev-ari

Vice President of Human Resource

Maria Rubin

Executive Vice President of Operations

Tal Vilnai

General Counsel & Corporate Secretary

Jonny MissulawinCFO

Chief Financial Officer

Dalit HazanCEO

Deputy Chief Executive Officer and Executive Vice President of R&D, Clinical & Regulatory Affairs

Jean-Marc Hagai Pharm.D.

Chief Commercial Officer

Nurit Tweezer-Zaks M.B.A., M.D.

Chief Medical Officer

Total 8 executives

PYPD Frequently asked questions

What is PolyPid Ltd. (PYPD) Stock Price?

Current stock price of PolyPid Ltd. (PYPD) stock is $5.300. The stock price is -0.56% lower in the session. The intraday range can be seen from this page. Volume of PolyPid Ltd. (PYPD) stock is 143.78K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the PolyPid Ltd. (PYPD) stock price going up or down today?

The stock price of PolyPid Ltd. (PYPD) can change with earnings, company news, and overall market sentiment. PolyPid Ltd. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the PolyPid Ltd. stock expensive at its current price?

Whether PolyPid Ltd. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for PYPD on this page is -3.58. EPS on this page is -1.48. Compare those figures with peers and growth expectations before deciding if the current PolyPid Ltd. price is justified.

How has the stock price of PolyPid Ltd. (PYPD) performed historically?

Historical performance for PolyPid Ltd. (PYPD) is shown on the price chart on this page. Review multi-period moves alongside volume to see how PYPD reacted to past earnings and market events.

Should I buy PolyPid Ltd. (PYPD) stock, at this price?

Buying PolyPid Ltd. (PYPD) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.